Since they gave a press release for the conference
Post# of 148301
1) where are we will the 100 patients at 700mg needed for safety data for BLA (or at least when they plan on updating us?)
Follow up, can they count the combo patients that were switched to 700mg or must they be mono only?
2) Why the TNBC trial delay? It has been a very long time since they have addressed this trial publicly.